LP173601-8
Ezogabine
Active
Description
Ezogabine or Retigabine, also known ad D-23129, is an anticonvulsant used as a treatment for partial epilepsies. Its primary active metabolite is N-acetyl ezogabine. Ezogabine works primarily as a potassium channel opener-that is, by activating a certain family of voltage-gated potassium channels in the brain. This mechanism of action is unique among antiepileptic drugs, and may hold promise for the treatment of other neurologic conditions, including migraine, tinnitus and neuropathic pain. Source: Regenstrief LOINC , Ezogabine
Basic Part Properties
- Part Name
- Ezogabine
- Part Display Name
- Ezogabine
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2013-07-30
- Construct for LOINC Short Name
- Ezogabine
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP173601-8 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP173601-8
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
zh-CN | Chinese (China) | 瑞替加滨 Synonyms: 依佐加滨; |
it-IT | Italian (Italy) | Ezogabina |
ru-RU | Russian (Russian Federation) | Эзогабин |
es-ES | Spanish (Spain) | Ezogabina |
tr-TR | Turkish (Turkey) | Ezogabin |
nl-NL | Dutch (Netherlands) | ezogabine |
el-GR | Greek (Greece) | Εζογκαμπίνη Synonyms: Εζογκαμπίνη |
LOINC Copyright
Copyright © 2025 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://